Egrifta OK’d for Excess Fat Due to AIDS Drugs
The FDA has approved Egrifta, administered by daily injection, for the treatment of HIV lipodystrophy -- fat accumulation that is a side effect of AIDS drugs.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.